DAY 1 - Thursday, 22 October 2026

Topic

Activity

Time

Learning objectives

Category

Speaker

Onsite Registration (08:00-08:45)

Opening and Welcome

Qur'an Recitation

8.45am

 Welcome speech

8.50am

KEYNOTE TALKS (9am to 10.30am) 90 min

MODERATORS:

Technologies Solutions Shaping Neuroscience

MODERATORS:

1

Neuroscience in the Age of Intelligent Systems: Innovation, Disruption, and the Human Factor

Presentation

9am (25 min)

Outline key applications of AI, robotics, and digital technologies in neuroscience practice.
Assess benefits and limitations of technology-enabled clinical decision-making.
Recognize ethical and human-factor challenges in AI-driven care.
Apply clinical judgment and leadership principles when integrating intelligent systems into practice.

1

Hilal Lashuel (Qatar)

2

Artificial Intelligence in Practice: How to use AI efficiently, logically and ethically in Healthcare

Presentation

9.25am (25 min)

Identify practical uses of AI in healthcare learning and clinical reasoning.
Apply AI tools efficiently and logically in practice.
Recognize ethical, academic, and professional standards in AI use.
Communicate AI-supported decisions clearly and responsibly.

1

Somaya Almaadeed (Qatar)

3

From Data to Decisions: Integrating AI, Robotics, and Digital Technologies into Neuroscience Care

Presentation

9.50am (25 min)

Identify real-world AI, robotic, and digital applications across neuroscience subspecialties.
Translate data-driven technologies into clinical decision-making.
Evaluate benefits and limitations of technology integration in complex care.
Integrate digital innovations safely within multidisciplinary workflows.

1

Shona Pederson (Qatar)

Panel Discussion

10.15am (15 min)

BREAK - 10.30am to 10.45am

PARALLEL SESSION 1 (10.45am to 12.30pm) 105 min

Innovations in Neuro-oncology

MODERATORS:

1

Advanced Imaging in Neuro-oncology

Presentation

10.45am (25 min)

Identify advanced imaging modalities used in neuro-oncology. Interpret imaging biomarkers for tumor characterization and treatment planning.
Differentiate tumor progression from treatment-related changes.
Apply advanced imaging findings to guide multidisciplinary neuro-oncology care.

1

Yahya Paksoy (Qatar)

3

Maximal Safe Resection in Gliomas

Presentation

11.10am (20 min)

Describe contemporary techniques enabling maximal safe glioma resection.
Define the role and indications of FLAIR-ectomy in glioma surgery.
Apply functional mapping/monitoring principles to preserve eloquent cortex and pathways.
Balance extent of resection with neurological risk to optimize oncologic and functional outcomes.

1

Ismail Ughratdar (UK)

4

Challenges in Recurrent Meningioma Surgery

Presentation

11.30am (20 min)

Identify key challenges in recurrent meningioma surgery (scarring, vascularity, prior RT).
Evaluate factors influencing extent of resection and operative risk.
Plan surgical strategy for tumors with critical vascular/cranial base involvement.
Counsel on expected outcomes, complications, and multimodal treatment options.

1

Fahad Alkherayf (Canada)

5

New Therapies for Brain Metastases: An Update

Presentation

11.50am (20 min)

Summarize recent targeted and immunotherapy advances for brain metastases (lung, breast
Identify candidates for systemic therapies and multimodal treatment.
Integrate systemic therapy with surgery/SRS to improve local control and survival.
Evaluate outcomes with emphasis on quality of life and neurocognitive preservation.

1

Salha Bujassom (Qatar)

Panel Discussion

12.10pm (20 min)

Innovation in Epilepsy and Seizure Disorders

MODERATORS:

1

Beyond Seizures: Psychiatric Comorbidities in Patients with Epilepsy

Presentation 

10.45am (25 min)

Describe current AI-enabled methods for EEG-based seizure detection.
Recognize updated EEG patterns and practical pitfalls in seizure identification.
Evaluate performance limits and clinical risks of automated detection systems.
Integrate AI-assisted EEG tools into real-world seizure monitoring workflows.

1

Taoufik Alsadi (UAE)

2

Startegies of Disconuation of Antiseizure Medications

Presentation 

11.10am (20 min)

Summarize current evidence guiding discontinuation of anti-epileptic medications.
Identify clinical and electrographic factors predicting seizure recurrence.
Apply risk–benefit assessment to individualized withdrawal decisions.
Implement safe tapering strategies and patient counseling in clinical practice.

1

Taoufik Alsadi (UAE)

3

Pre-surgical Evaluation and Indications for Epilepsy Surgery

Presentation 

11.30am (20 min)

Describe the components of comprehensive pre-surgical evaluation for epilepsy.
Identify indications and timing for epilepsy surgery referral.
Interpret EEG, imaging, and functional studies for surgical candidacy.
Apply multidisciplinary decision-making to select appropriate surgical strategies.

1

Ismail ughratdar (UK)

4

Seizure Simiology: lateralization and localizing signs

Presentation 

11.50am (20 min)

Identify key seizure semiologic features relevant to localization and lateralization.
Differentiate focal seizure patterns linked to specific cortical regions.
Apply semiologic signs to presurgical and diagnostic evaluation.
Integrate semiology with EEG and imaging for accurate localization.

1

Gayane Melikyan (Qatar)

Panel Discussion

12.10pm (20 min)

LUNCH BREAK - 12.30pm to 1.30pm

PARALLEL SESSION 2 (1.30pm to 3pm) 90 min

Multi-dsiciplinary Approaches in Neuro-oncology

MODERATORS:

1

Precision Neuro-Oncology: Molecular-Guided approaches

 Presentation

1.30pm (20 min)

Describe key molecular alterations driving precision neuro-oncology.
Interpret molecular profiling results to guide diagnosis and risk stratification.
Apply molecular-guided strategies to treatment selection and trial eligibility.
Integrate molecular data into multidisciplinary neuro-oncology decision-making.

1

TBC

2

Emerging Medical Therapies for High-Grade Gliomas

 Presentation

1.50pm (20 min)

Outline emerging therapies for high-grade gliomas (TTF, immunotherapy, targeted agents, vaccines).
Summarize current evidence and key clinical trials shaping practice.
Identify patients suitable for novel therapies and trial enrollment.
Integrate emerging treatments into multidisciplinary glioma care.

1

Ghaya Al-Rumaihi (Qatar)

3

Evolving Radiotherapy Strategies in Gliomas

 Presentation

2.10pm (15 min)

Describe evolving radiotherapy approaches in gliomas, including hypofractionation.
Apply advanced imaging to optimize precision radiotherapy planning.
Integrate molecular profiling and novel therapies into radiotherapy strategies.
Balance tumor control with preservation of neurocognitive function.

1

 Raphael Bodensohn (Germany)

4

Rehabilitation Strategies After Brain Tumor Treatment

 Presentation

2.25pm (15 min)

Identify key rehabilitation strategies following brain tumor treatment.
Apply technology-enabled interventions to support recovery.
Leverage neuroplasticity principles to enhance functional outcomes.
Integrate multidisciplinary rehabilitation to improve quality of life.

1

Fary Khan (Qatar)

Panel Discussion

2.40pm (20 min)

BREAK 3pm to 3.15pm

PARALLEL SESSION 3 (3.15 to 5pm) 105 min

Trends in Neurophysiology and Neuromascular Disorders

MODERATORS:

1

From Autonomic Function Testing to Establishing an Autonomic Laboratory

Presentation

3.15pm (25 min)

Identify diagnostic approaches for autoimmune and autonomic dysfunction.
Outline key components required to establish an autonomic laboratory.
Recognize major autonomic disorders and their clinical presentations.
Apply current treatment strategies for autonomic disorders in practice.

1

Mohamed Kazamel (USA)

2

Idiopathic Inflammation Myosisitis: New Classification and Diagnosis

Presentation

3.40pm (20 min)

Outline the updated classification systems for idiopathic inflammatory myopathies.
Identify key clinical, serologic, and imaging features used in diagnosis.
Differentiate major myositis subtypes using contemporary diagnostic criteria.
Apply integrated diagnostic approaches to guide precision management.

1

Hassan Al husain (Qatar)

3

Update on GBS Diagnosis and Treatment

Presentation

4pm (20 min)

Identify updated diagnostic criteria for Guillain–Barré syndrome.
Differentiate major clinical and electrophysiological subtypes.
Summarize current evidence-based treatment strategies.
Apply timely management principles to improve patient outcomes.

1

Mohammed Alhatou (Qatar)

5

Electrodiagnostic Evaluation of Myasthenia Gravis

Presentation

4.20pm (20 min)

Describe the role of electrodiagnostic studies in diagnosing myasthenia gravis.
Interpret key findings on repetitive nerve stimulation and single-fiber EMG.
Differentiate myasthenia gravis from other neuromuscular junction disorders using EDX.
Apply electrodiagnostic results to support clinical diagnosis and management.

1

Mohamed Kazamel (USA)

Panel Discussion

4.40pm (20 min)

Modern Approaches to Head Trauma

MODERATORS:

1

Head Injury Trends in Qatar: Trauma Registry Data

Presentation

3.15pm (25 min)

Describe epidemiological trends in head injury in Qatar using trauma registry data.
Identify common mechanisms of injury and outcome predictors.
Apply registry insights to improve clinical pathways and resource planning.
Develop targeted prevention strategies based on local data.

1

Gustav Strandvik (Qatar)

2

Clinical and Radiological Predictors of TBI Outcome

Presentation

3.40pm (20 min)

Identify key clinical and radiological predictors of TBI outcomes at presentation.
Apply early assessment tools to stratify severity and risk.
Interpret imaging markers relevant to prognosis and treatment planning.
Integrate admission predictors into individualized management decisions.

1

Mark Wilson (UK)

3

Guideline-Driven Management of Head Injury

Presentation

4pm (20 min)

Summarize current evidence-based guidelines for acute TBI management.
Identify key recommendations and areas of controversy.
Apply guideline principles to common acute head injury scenarios.
Evaluate adherence and barriers to implementation in practice.

1

Mark Wilson (UK)

4

Decision-Making in Salvageable and Non-Salvageable TBI

Presentation

4.20pm (20 min)

Differentiate salvageable from non-salvageable TBI using clinical and radiological criteria.
Apply prognostic tools to support timely decision-making.
Integrate ethical principles into escalation or limitation of care decisions.
Communicate prognosis and goals of care effectively with families and teams.

1

Arshad Ali (Qatar)

Panel Discussion

4.40pm (20 min)

Precision Approaches in Neurocritical Care

MODERATORS:

1

Precision Managment in Head injury

Presentation

3.15pm (25 min)

Describe precision monitoring targets in TBI (ICP/CPP, PbtO₂, microdialysis).
Apply individualized ICP/CPP optimization strategies at the bedside.
Interpret PbtO₂ and microdialysis trends to guide therapy.
Integrate multimodal data to tailor patient-specific TBI management.

1

Vishi Verma (UK)

2

Medical Management in Spontaneous Intracranial Hemorrhages - ICH in 2026

Presentation

3.40pm (20 min)

Summarize current guideline-based medical management of spontaneous ICH (ESO 2025, AHA 2022).
Apply evidence-based blood pressure control strategies in acute ICH.
Identify key clinical and radiological factors influencing prognosis and outcome.
Integrate guideline recommendations into individualized acute ICH care pathways.

1

Victor C. Urrutia (USA)

3

Advances in Medical Management of Aneurysmal SAH

Presentation

4pm (20 min)

Describe recent advances in the medical management of aneurysmal SAH.
Interpret emerging biomarkers for prognostication and risk stratification.
Apply contemporary fluid monitoring and management strategies.
Integrate prognostic insights to optimize outcomes and clinical decision-making.

1

Nissar Sheikh (Qatar)

4

Controversies and Challenges in End-of life Care

Presentation

4.20pm (20 min)

Describe key principles and controversies in end-of-life care in neurocritical settings.
Apply brainstem death criteria and documentation standards in practice.
Evaluate decision-making around withdrawal of life-sustaining therapies.
Integrate ethical frameworks into communication and goals-of-care discussions.

1

Aljazi Al-Mana (Qatar)

Panel Discussion

4.40pm (20 min)

END OF DAY 1 SESSIONS - 5pm